Literature DB >> 30179396

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.

Marek Lommatzsch1,2, Kai Bratke1, Paul Stoll1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30179396     DOI： 10.1056/NEJMc1808251

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

1.  NeoScore Integrates Characteristics of the Neoantigen:MHC Class I Interaction and Expression to Accurately Prioritize Immunogenic Neoantigens.

Authors:  Elizabeth S Borden; Suhail Ghafoor; Kenneth H Buetow; Bonnie J LaFleur; Melissa A Wilson; K Taraszka Hastings
Journal:  J Immunol       Date:  2022-03-18       Impact factor: 5.426

2.  Genomics-based immuno-oncology: bridging the gap between immunology and tumor biology.

Authors:  Renzo G DiNatale; A Ari Hakimi; Timothy A Chan
Journal:  Hum Mol Genet       Date:  2020-10-20       Impact factor: 6.150

3.  Incidence, clinicopathologic, and genetic characteristics of mismatch repair gene-mutated glioblastomas.

Authors:  Yoon Ah Cho; Deokgeun Kim; Boram Lee; Joon Ho Shim; Yeon-Lim Suh
Journal:  J Neurooncol       Date:  2021-04-17       Impact factor: 4.130

Review 4.  The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications.

Authors:  Yuanyuan Zhang; Zemin Zhang
Journal:  Cell Mol Immunol       Date:  2020-07-01       Impact factor: 11.530

5.  Expression signature, prognosis value, and immune characteristics of Siglec-15 identified by pan-cancer analysis.

Authors:  Baihui Li; Bailu Zhang; Xuezhou Wang; Ziqing Zeng; Ziqi Huang; Lin Zhang; Feng Wei; Xiubao Ren; Lili Yang
Journal:  Oncoimmunology       Date:  2020-08-28       Impact factor: 8.110

Review 6.  [Progress on PD-1/PD-L1 Checkpoint Inhibitors in Lung Cancer].

Authors:  Di Zhang; Jiaqi Huang; Chufeng Zhang; Yan Guan; Qisen Guo
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2019-06-20

7.  Bronchopleural fistula following a video-assisted thoracoscopic surgery lobectomy after neoadjuvant therapy of pembrolizumab: a case report and literature review.

Authors:  Min Cao; Yujie Fu; Xiuying Xiao; Jian Tang; Daoqiang Tang; Xiaojing Zhao
Journal:  Ann Transl Med       Date:  2020-12

8.  Neoadjuvant programmed cell death protein 1 inhibitors combined with chemotherapy in resectable non-small cell lung cancer: an open-label, multicenter, single-arm study.

Authors:  Hongtao Duan; Tianhu Wang; Zhilin Luo; Liping Tong; Xiaoping Dong; Yong Zhang; Muhammad Zubair Afzal; Pierpaolo Correale; Honggang Liu; Tao Jiang; Xiaolong Yan
Journal:  Transl Lung Cancer Res       Date:  2021-02

9.  The efficiency of 18F-FDG PET-CT for predicting the major pathologic response to the neoadjuvant PD-1 blockade in resectable non-small cell lung cancer.

Authors:  Xiuli Tao; Ning Li; Ning Wu; Jie He; Jianming Ying; Shugeng Gao; Shuhang Wang; Jie Wang; Zhijie Wang; Yun Ling; Wei Tang; Zewei Zhang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-02-11       Impact factor: 9.236

10.  Development of a prognostic index and screening of potential biomarkers based on immunogenomic landscape analysis of colorectal cancer.

Authors:  Kang Lin; Jun Huang; Hongliang Luo; Chen Luo; Xiaojian Zhu; Fanqin Bu; Han Xiao; Li Xiao; Zhengming Zhu
Journal:  Aging (Albany NY)       Date:  2020-03-31       Impact factor: 5.682
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.